From: Leveraging hybrid biomarkers in clinical endpoint prediction
Biomarkers | Univariable | Multivariable | ||
---|---|---|---|---|
HR | 95% CI | HR | 95% CI | |
Demographic factors | ||||
Age | ||||
  ≤ 70 | 1 |  | 1 |  |
  > 70 | 2.235 | 1.097–4.556a | 2.257 | 1.240–4.111 |
Gender | ||||
 Male | 1 |  |  | |
 Female | 1.015 | 0.560–1.837 | ||
Weights | ||||
  ≤ 150 | 1 |  |  | |
  > 150 | 1.070 | 0.604–1.897 | ||
Smoking Status | ||||
 Yes | 1 |  |  | |
 No | 1.623 | 0.872–3.021 | ||
Clinical factors | ||||
Primary Tumor | ||||
  ≤ T2 | 1 |  |  | |
  > T2 | 0.904 | 0.446–1.830 | ||
Lymph Node | ||||
 N0 | 1 |  | 1 |  |
  ≥ N1 | 3.797 | 1.038–13.887a | 4.163 | 1.858–9.326 |
Metastasis | ||||
 M0 | 1 |  |  | |
 M1 | 4.863 | 0.238–99.479a | ||
Histology | ||||
 Squamous | 1 |  |  | |
 Non-Squamous | 1.194 | 0.582–2.452 | ||
Tumor size | ||||
 Longest diameter | 1.059 | 1.010–1.110a |  |